Matinas BioPharma Holdings Inc./$MTNB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Matinas BioPharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Ticker
$MTNB
Sector
Primary listing
AMEX
Employees
3
Headquarters
Website
MTNB Metrics
BasicAdvanced
$9.7M
-
-$3.87
-
-
Price and volume
Market cap
$9.7M
52-week high
$3.09
52-week low
$0.47
Average daily volume
949K
Financial strength
Current ratio
4.074
Quick ratio
3.658
Long term debt to equity
22.254
Total debt to equity
32.964
Interest coverage (TTM)
-6,101.50%
Profitability
EBITDA (TTM)
-11.988
Effective tax rate (TTM)
0.41%
Management effectiveness
Return on assets (TTM)
-42.62%
Return on equity (TTM)
-146.46%
Valuation
Price to book
1.15
Price to tangible book (TTM)
1.15
Price to free cash flow (TTM)
-0.8
Free cash flow yield (TTM)
-124.98%
Free cash flow per share (TTM)
-2.175
Growth
Earnings per share change (TTM)
-23.89%
3-year earnings per share growth (CAGR)
-13.02%
10-year earnings per share growth (CAGR)
-11.83%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Matinas BioPharma Holdings Inc. stock?
Matinas BioPharma Holdings Inc. (MTNB) has a market cap of $9.7M as of August 22, 2025.
What is the P/E ratio for Matinas BioPharma Holdings Inc. stock?
The price to earnings (P/E) ratio for Matinas BioPharma Holdings Inc. (MTNB) stock is 0 as of August 22, 2025.
Does Matinas BioPharma Holdings Inc. stock pay dividends?
No, Matinas BioPharma Holdings Inc. (MTNB) stock does not pay dividends to its shareholders as of August 22, 2025.
When is the next Matinas BioPharma Holdings Inc. dividend payment date?
Matinas BioPharma Holdings Inc. (MTNB) stock does not pay dividends to its shareholders.
What is the beta indicator for Matinas BioPharma Holdings Inc.?
Matinas BioPharma Holdings Inc. (MTNB) does not currently have a Beta indicator.